ArticleFrontiers in medicine2026
RTS-Net: thyroid nodule segmentation network integrating dual-path attention and graph convolution.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Thyroid ultrasound is the primary imaging modality for nodule detection, but manual interpretation suffers from subjectivity and inefficiency due to speckle noise, low contrast, and operator dependence. Deep learning-based segmentation methods often overlook anatomical prior information, leading to suboptimal performance on atypical nodules and complex backgrounds. Methods: We propose RTS-Net, a novel segmentation network that integrates a dual-path attention enhancement mechanism (combining spatial and channel attention) and a cascaded graph convolution decoding architecture to leverage multi-scale feature pyramid fusion. A deep supervision strategy is also employed to accelerate convergence. The model is trained and evaluated on the TN3K, DDTI, and a large-scale clinical dataset. Results: Extensive experiments demonstrate that RTS-Net achieves superior performance on both in-distribution and cross-dataset settings. On the TN3K dataset, it attains 81.66% F1-score and 71.87% IoU; on the DDTI dataset, it achieves 71.10% F1-score and 60.09% IoU, outperforming state-of-the-art methods including UNet, DeepLabv3+, TransUNet, and recent foundation-model-based approaches. Ablation studies confirm the effectiveness of each proposed component. Discussion: The proposed dual-path attention and graph convolution modules effectively enhance feature representation and boundary integrity, particularly for small nodules and blurred edges. While RTS-Net shows strong generalization, failure cases reveal challenges in heterogeneous backgrounds and acoustic artifacts, suggesting future integration with foundation models like SAM to further improve robustness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.